Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on March 14, 2025
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 14, 2025
SOUTH SAN FRANCISCO, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Great Lakes Announces $50 Million Share Repurchase Program
GlobeNewswire
·
March 14, 2025
HOUSTON, March 14, 2025 (GLOBE NEWSWIRE) -- Great Lakes Dredge …
ORYZON to Provide Corporate Progress Updates at Several Events in March-April
GlobeNewswire
·
March 14, 2025
BIO-Europe Spring 2025 Van Lanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging …
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
GlobeNewswire
·
March 14, 2025
SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will …
Global Uranium Corp. Announces Private Placement for up to C$1,000,000
GlobeNewswire
·
March 14, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | FRA: Q3J) (the “Company”) is pleased to announce a non- …
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
GlobeNewswire
·
March 14, 2025
CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, …
SalesHood Recognized in the 2025 Gartner® Market Guide for Digital Sales Rooms
GlobeNewswire
·
March 14, 2025
San Francisco, March 14, 2025 (GLOBE NEWSWIRE) -- SalesHood, a leading AI-driven sales enablement platform, is proud to announce its recognition as a Representative Vendor in the 2025 Gartner Market Guide for Digital Sales Rooms. According to Gartner, “ …
Nuvectis Pharma to Participate in the 37th Annual Roth Conference
GlobeNewswire
·
March 14, 2025
FORT LEE, NJ, March 14, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in …
MicroCloud Hologram Inc. Researches an Efficient High-Dimensional Quantum Key Distribution Protocol Based on Quantum Fourier Transform for Quantum Transmission
GlobeNewswire
·
March 14, 2025
SHENZHEN, China, March 14, 2025 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, they announced the proposal of an efficient high-dimensional quantum key distribution protocol for …
Primech AI to Showcase HYTRON AI-Powered Autonomous Bathroom Cleaning Robot at RoboSG 2025
GlobeNewswire
·
March 14, 2025
SINGAPORE, March 14, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. ("Primech AI") or (the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced its participation at RoboSG 2025, where it will showcase HYTRON, its …
illumin Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 14, 2025
Fourth Quarter Revenue shows Growth Across All Service Lines by 35% YoY to $49.9 Million Full Year Revenue Grows 11% YoY to $140.4 Million Self-Service Revenue Grew by 45% YoY for the Quarter and 78% for the Full Year Adjusted EBITDA Improved by 42% YoY …
Porsche placed first in J.D. Power 2025 U.S. Customer Service Index Study
GlobeNewswire
·
March 14, 2025
ATLANTA, March 14, 2025 (GLOBE NEWSWIRE) -- Porsche Cars North America, Inc. (PCNA) and its network of more than 200 dealers earned the number one ranking overall in the J.D. Power 2025 U.S. Customer Service Index Study (CSI) released Thursday. Porsche …
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
GlobeNewswire
·
March 14, 2025
BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
CareCloud Announces Preferred Stock Dividend Payments
GlobeNewswire
·
March 14, 2025
SOMERSET, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its …
Mirasol Resources Announces Shareholder Loan Transaction
GlobeNewswire
·
March 14, 2025
VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Mirasol Resources Ltd. ("Mirasol") is pleased to announce that it has obtained a loan of $2,000,000 (the “Loan”) from Mr. John Tognetti, a director and control person of Mirasol. The Loan …
Apollo Silver Engages Danayi Capital for Investor Relations and Digital Marketing Services
GlobeNewswire
·
March 14, 2025
VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo Silver” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce that it has engaged Danayi Capital Corp. (“Danayi”), an arm’s-length …
Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025
GlobeNewswire
·
March 14, 2025
SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call …
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
GlobeNewswire
·
March 14, 2025
- Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study - - Company expects to submit New Drug Application (NDA) in April 2025 - DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” …
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
GlobeNewswire
·
March 14, 2025
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin marketing ILUVIEN in the U.S. under the combined label later this …
Dundee Precious Metals Announces Renewal of Normal Course Issuer Bid
GlobeNewswire
·
March 14, 2025
TORONTO, March 14, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (the “Company”) announced today that the Toronto Stock Exchange (“TSX”) accepted its notice of intention to renew its normal course issuer bid (the “New Bid”) to purchase …